Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies

Zoe Waibler, Linda Y. Sender, Camilla Merten et al. · 2008

Read Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies by Zoe Waibler, Linda Y. Sender, Camilla Merten et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001708.txt.

Description

Zoe Waibler, Linda Y. Sender, Camilla Merten, and their co-authors profiled powerful immune-activating antibodies in a 2008 PLOS ONE research article. Superagonistic CD28 antibodies switch T cells on without the usual co-signal from the T-cell receptor complex. In rodents they expand regulatory T cells and can treat autoimmune disease. In a human trial, though, such an antibody caused severe harm, making its signals a safety question.

The team mapped the signaling signatures and functional properties of anti-human CD28 superagonists. The full text gives the cell tests and which pathways fired. Knowing exactly what these antibodies do in human cells is a precondition for any safe return of the class. It is also a case study in how animal results can mislead.

Catalog record

CREATORZoe Waibler, Linda Y. Sender, Camilla Merten et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001708

Browse the full library · About the Tower of Babel